On Air Now Josh Beaven Live from the Hilton Barbados Resort 7:00pm - Midnight Post Malone - Chemical Schedule

BREAKING: UK Becomes First Country To Approve 'Game Changing' Pill To Treat COVID

The UK has become the first country to approve Merck's "game changing" pill to treat COVID.

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved Merck Sharp & Dohme's (MSD) molnupiravir for use in the UK.

The pill, which is taken orally, "is safe and effective at reducing the risk of hospitalisation and death in people with mild to moderate COVID-19 who are at increased risk of developing severe disease," according to a statement.

Health Secretary Sajid Javid said:

"Today is a historic day for our country, as the UK is now the first country in the world to approve an antiviral that can be taken at home for COVID-19. 

"This will be a gamechanger for the most vulnerable and the immunosuppressed, who will soon be able to receive the ground-breaking treatment."

He added:

"We are working at pace across the government and with the NHS to set out plans to deploy molnupiravir to patients through a national study as soon as possible."

Also known as Lagevrio, the drug was developed Ridgeback Biotherapeutics and Merck Sharp & Dohme (MSD).

The statement from the MHRA added:

"Based on the clinical trial data, Lagevrio is most effective when taken during the early stages of infection and so the MHRA recommends its use as soon as possible following a positive COVID-19 test and within five days of symptoms onset

"Molnupiravir has been authorised for use in people who have mild to moderate COVID-19 and at least one risk factor for developing severe illness. Such risk factors include obesity, older age (>60 years), diabetes mellitus, or heart disease."

More from Isle of Wight News